- Home
- Publications
- Publication Search
- Publication Details
Title
The Evolution of Ovarian Carcinoma Subclassification
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 2, Pages 416
Publisher
MDPI AG
Online
2022-01-15
DOI
10.3390/cancers14020416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability
- (2021) Raunak Shrestha et al. CANCER RESEARCH
- Can integrative biomarker approaches improve prediction of platinum and PARP inhibitor response in ovarian cancer?
- (2021) Ionut-Gabriel Funingana et al. SEMINARS IN CANCER BIOLOGY
- Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature
- (2021) Giacomo Santandrea et al. Diagnostics
- Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma
- (2021) Katharina Wiedemeyer et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases
- (2021) Edaise M. da Silva et al. MODERN PATHOLOGY
- Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
- (2021) Kazuaki Takahashi et al. Cancers
- What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors
- (2021) Antonio De Leo et al. Diagnostics
- Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype
- (2021) Monica Rodriguez et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research
- (2021) Shama Virani et al. CARCINOGENESIS
- Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary
- (2021) Rachel Sue-A-Quan et al. GYNECOLOGIC ONCOLOGY
- Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma
- (2021) Saira Khalique et al. Cancers
- The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor Blocks
- (2021) Lise M. van Wijk et al. Cancers
- Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
- (2021) Robert L. Hollis et al. npj Precision Oncology
- Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
- (2021) Sherry Shen et al. Gynecologic Oncology Reports
- DNA Methylation Profiles of Ovarian Clear Cell Carcinoma
- (2021) Julie M. Cunningham et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8 + TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas
- (2021) Karolin Heinze et al. JOURNAL OF PATHOLOGY
- MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
- (2021) Eun Young Kang et al. VIRCHOWS ARCHIV
- Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features
- (2021) Eun Young Kang et al. Journal of Pathology Clinical Research
- Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
- (2020) Marta Llaurado Fernandez et al. GYNECOLOGIC ONCOLOGY
- Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes
- (2020) Stephanie A. Scott et al. GYNECOLOGIC ONCOLOGY
- Therapeutic options for mucinous ovarian carcinoma
- (2020) Kylie L. Gorringe et al. GYNECOLOGIC ONCOLOGY
- Molecular Heterogeneity of Endometrioid Ovarian Carcinoma
- (2020) Susanna Leskela et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prognostic gene expression signature for high-grade serous ovarian cancer
- (2020) J. Millstein et al. ANNALS OF ONCOLOGY
- Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
- (2020) Pauline Krämer et al. CLINICAL CANCER RESEARCH
- Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
- (2020) Aline Talhouk et al. CLINICAL CANCER RESEARCH
- Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
- (2020) Eun Young Kang et al. MODERN PATHOLOGY
- Combined CCNE1 high‐level amplification and overexpression is associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma
- (2020) Angela MY Chan et al. Journal of Pathology Clinical Research
- Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities
- (2020) Dane Cheasley et al. JOURNAL OF PATHOLOGY
- Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
- (2020) Robert L. Hollis et al. Nature Communications
- The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas
- (2020) Lise M. van Wijk et al. Cancers
- Primary mucinous ovarian neoplasms rarely show germ cell histogenesis
- (2020) Felix K F Kommoss et al. HISTOPATHOLOGY
- The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting
- (2020) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
- (2020) Yu-Chien Lin et al. Journal of Ovarian Research
- Proteomics derived biomarker panel improves diagnostic precision to classify endometrioid and high-grade serous ovarian carcinoma
- (2019) Lynne-Marie Postovit et al. CLINICAL CANCER RESEARCH
- Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype
- (2019) Masataka Takenaka et al. CLINICAL CANCER RESEARCH
- A Comprehensive Review of Ovarian Serous Carcinoma
- (2019) Yuichiro Hatano et al. ADVANCES IN ANATOMIC PATHOLOGY
- Low-grade Serous Carcinoma Arising in Inguinal Nodal Endosalpingiosis
- (2019) Shatrughan Sah et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Oncogenic mutations in histologically normal endometrium: the new normal?
- (2019) Vivian Lac et al. JOURNAL OF PATHOLOGY
- A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
- (2019) Nicola S. Meagher et al. MODERN PATHOLOGY
- Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma
- (2019) Robert L. Hollis et al. GYNECOLOGIC ONCOLOGY
- The molecular origin and taxonomy of mucinous ovarian carcinoma
- (2019) Dane Cheasley et al. Nature Communications
- High-grade Endometrioid Carcinoma of the Ovary
- (2018) Hisham Assem et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Ovarian Carcinoma Histotype
- (2018) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Histotype classification of ovarian carcinoma: A comparison of approaches
- (2018) Lauren C. Peres et al. GYNECOLOGIC ONCOLOGY
- Copy number signatures and mutational processes in ovarian carcinoma
- (2018) Geoff Macintyre et al. NATURE GENETICS
- Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome
- (2018) Linyuan Wang et al. HISTOPATHOLOGY
- Iatrogenic endometriosis harbors somatic cancer-driver mutations
- (2018) V Lac et al. HUMAN REPRODUCTION
- Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma
- (2018) Randi Woodbeck et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications
- (2017) Peter Rambau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?
- (2017) Dawn R Cochrane et al. JOURNAL OF PATHOLOGY
- Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups
- (2017) Carlos Parra-Herran et al. MODERN PATHOLOGY
- Cancer-Associated Mutations in Endometriosis without Cancer
- (2017) Michael S. Anglesio et al. NEW ENGLAND JOURNAL OF MEDICINE
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
- (2017) et al. JAMA Oncology
- Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes
- (2016) Ryusuke Murakami et al. AMERICAN JOURNAL OF PATHOLOGY
- Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome
- (2016) Jesse K. McKenney et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Mismatch Repair Protein Expression in Clear Cell Carcinoma of the Ovary
- (2016) Jennifer A. Bennett et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Ovarian carcinoma diagnosis: the clinical impact of 15 years of change
- (2016) Stefan Kommoss et al. BRITISH JOURNAL OF CANCER
- Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas
- (2016) Marie McFarland et al. HISTOPATHOLOGY
- Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas
- (2016) Peter F Rambau et al. HISTOPATHOLOGY
- An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
- (2016) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas
- (2016) Mackenzie Coatham et al. MODERN PATHOLOGY
- Ovarian Seromucinous Carcinoma
- (2015) Jennifer Taylor et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers
- (2015) Robertson Mackenzie et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin
- (2015) Yihong Wang et al. JOURNAL OF PATHOLOGY
- Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry
- (2013) Martin Köbel et al. HISTOPATHOLOGY
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors
- (2013) Alon D Altman et al. MODERN PATHOLOGY
- Synthetic lethality between CCNE1 amplification and loss of BRCA1
- (2013) D. Etemadmoghadam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
- (2012) Roel G.W. Verhaak et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
- (2011) Robert A Soslow et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible
- (2010) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
- (2009) D. Etemadmoghadam et al. CLINICAL CANCER RESEARCH
- A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
- (2008) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started